Authors

  1. Peruhype, Rarianne Carvalho
  2. Bath-Hextall, Fiona
  3. Galvao, Cristina Maria
  4. Darlington, Nicola
  5. Palha, Pedro Fredemir

Abstract

Review question/objective: What are the most effective educational interventions that are used to improve patients' outcomes via improvement of health professionals' knowledge and practice in the Direct Observed Therapy of Tuberculosis and the Directly Observed Therapy Short-Course (DOTS) strategy?

 

Background: Tuberculosis (TB) is a major concern for global public health. Although considered a curable disease, its incidence has continued to rise in certain regions. In Europe, for example, the rates of reported cases of TB (per 100,000 inhabitants) have increased considerably, ranging from 74.4 in 1997 to 104 in 2004. There are great disparities among countries in this continent with respect to TB infection. While Ireland and England showed less than 13 cases per 100,000 inhabitants in 2004, Romania and Russia had more than 100 estimated cases of TB per 100,000 inhabitants and the European part of Kazakhstan had 216 cases per 100,000 inhabitants, in the same period.1 India and China reported incidence rates of TB around 168/100,000 and 102/100,000 inhabitants in 2003, while Zimbabwe and Kenya presented even more concerning figures of 659/100,000 and 610/100,000 cases of all forms of TB, respectively.2

 

According to the 2011 World Health Organization (WHO) report, "India and China accounted for 40% of the world's notified cases of TB in 2010; Africa accounted for a further 24% of which one quarter were in South Africa and the 22 high-TB burden countries accounted for 82% of all notified cases in the world".3(p28) In 2011, there were approximately nine million new cases of TB and 1.4 million deaths associated with the disease worldwide.4

 

Aware of the alarming condition of the disease around the world and aiming to decrease the incidence and the global spread of TB, in 1997 the WHO promoted the Direct Observed Treatment Short Course (DOTS), one of the components of The Stop TB Partnership's 'Global Plan to Stop TB 2011-2015'.5

 

The DOTS strategy consists of five elements stated by WHO as: 1) Political commitment with increased and sustained financing; 2) Case detection through quality-assured bacteriology; 3) Standardized treatment, with supervision and patient support; 4) An effective drug supply and management system and 5) Monitoring and evaluation system, and impact measurement.6 Standardized treatment, known also as Direct Observed Therapy or Supervised Treatment/Therapy of TB, can be described as the activity of systematically and regularly monitoring the anti-TB drug intake by the patient. It can be performed by any health professional (physician, nurses, technicians, etc.) or any other provider (relatives, community members, cured TB patients, neighbors, or friends) who are trained and qualified to undertake this activity. Supervision can be undertaken at a health facility, in the workplace, in the community or at home.7,8

 

The WHO assigns the training and monitoring activities of non-medical treatment observers to the National Tuberculosis Control Program (NTP):

 

"There must be a clearly defined line of accountability from NTP staff to general health service staff and the treatment supporter[horizontal ellipsis] Detailed instructions for informing the patient and family about TB and its treatment and for arranging supervised treatment (including identifying and preparing a community TB treatment supporter) are contained in WHO's training modules for health facility staff".7(p78)

 

Guidelines on supervised treatment, TB control and community involvement can be found at the WHO databases and can underpin training processes.

 

Regarding the importance of undertaking DOTS, evidence suggests that it is possible to achieve up to a 90% cure rate when anti-TB drugs are correctly used.9 Supervised treatment is therefore an important strategy to not only ensure drug ingestion by the patient, but also to promote adherence to treatment, to increase the chances of cure and to decrease the odds of probable drug resistance, which seems to be the major consequence in contexts of noncompliance by the patient.10 In San Francisco, California, for example, the proportion of cure, mortality due to TB and drug resistance in 149 patients with pulmonary TB using supervised treatment was respectively 97.8%, 0% and 0%, while those undergoing self-administered therapy (223 patients) achieved 88.6% (cure), 5.5% (mortality due to TB) and 0.9% (drug resistance).11 In Sao Jose do Rio Preto, Brazil, the percentage of cure increased from 61.06% (1998) to 69.85% (2003) and the noncompliance with drug treatment reduced from 18.7% to 1.5% after the supervised treatment implementation in health services.12

 

Since the adoption of the DOTS strategy and the stop TB partnership plan, many countries have seen a notable reduction in the number of TB cases and deaths related to TB. The WHO Global Tuberculosis Report 2012 stated that "between 1995 and 2011, 51 million people were successfully treated for TB in countries that had adopted the DOTS/stop TB strategy (out of a total of 60 million treated)".4(p31) TB mortality rate has decreased by 41% since 1990 and the world seems to be in the right path to achieve the global targets of a 50% reduction by 2015. TB incidence rate (including HIV) in the Americas, for example, decreased from 59/100,000 inhabitants (1990) to 28/100,000 (2011). In the Western Pacific this rate reduced from 159/100,000 (1990) to 92/100,000 (2011).4 In Peru, the use of DOTS for more than five years resulted in successful treatment of 91% of cases.13

 

However, TB incidence still remains high in some continents such as in Africa, where the TB incidence rate increased from 245/100,000 inhabitants (1990) to 262/100,000 (2011).4 According to the 2007 WHO report, until 2005 there were still 25 out of 212 WHO member states which had not adopted the DOTS strategy,14 which perhaps influences the TB rates in those countries.

 

Thus, acknowledging the important contribution that the DOTS strategy, and particularly supervised treatment, can make in combating tuberculosis and increasing cure, this review will investigate the educational methods used by health institutions or health authorities to enhance the knowledge of health professionals, whether in the overall DOTS strategy or only in the supervised treatment of tuberculosis and how it can impact on TB cases as well on patient related outcomes such as cure, compliance, mortality and dropout rates.

 

It is known that the qualification of human resources in health or the lack of it can vastly influence TB rates. Accordingly to Munoz et al., 18 out of the 22 NTP managers of the TB high-burden countries ranked inappropriate human resources as the top constraint in order to reach the WHO global TB control objectives.15 The lack of adequately qualified or trained staff at different service levels was emphasized among other aspects.

 

In fact, information transfer and sharing, when appropriately done, can generate relevant knowledge which can then be converted into innovative actions by the health professionals in their workplaces. Albagli and Maciel believe in the "inseparability among the cognitive, informational, innovative and sociospatial dynamic" and claim that the use of information, knowledge and production of innovations can be characterized as a sociocultural process, bounded by a space and its own creation.16

 

Thus the analysis of the educational interventions used in health professionals' training on the DOTS strategy and supervised treatment can be seen as an opportunity to investigate not only the results of applying the theoretical knowledge in practice and the probable influence on TB incidence rates and patient-related outcomes, but also an opportunity to assess what type of educational measures were considered more suitable and effective in certain health contexts. On this regard, there will probably have been several and different training designs/types of educational interventions and also a variety of trainers, which could perhaps change from place to place, health institution to health institution, or from country to country, for example.

 

It is important to mention that in this review, educational intervention will be considered as any type of information or communication resource such as printed and illustrative material (flipcharts, posters, pamphlets, flyers, guidelines), educational workshops and meetings, lectures and seminars, among others.

 

A preliminary search of the Joanna Briggs Institute Database of Systematic Reviews and Implementation Reports, the Cochrane Library, CINAHL, PubMed and PROSPERO has revealed that there is not currently a systematic review, either published or underway, on this topic.

 

Article Content

Inclusion criteria

Types of participants

All categories of health professionals directly involved in Direct Observed Therapy of Tuberculosis (DOT) and Directly Observed Therapy Short-Course (the overall DOTS strategy), working either in hospital settings, the public health field or other health sectors.

 

Types of interventions

This review will consider studies that evaluate educational interventions used by health institutions or health authorities in order to improve patients' health by enhancing the knowledge and practice of health professionals regarding the DOTS strategy and DOT (supervised therapy/treatment of Tuberculosis).

 

The educational interventions can be compared to another type of educational intervention, or to no education.

 

Types of outcomes

Educational knowledge and practice outcomes are intermediary outcomes, but the main outcomes of interest are patient-related outcomes.

 

The primary outcome of interest for this review is the number of TB cases (smear positive TB patients) detected by the health professionals.

 

Secondary outcomes of interest for this review are:

 

Compliance as measured by counting the number of patients completing TB treatment;

 

Dropout attrition rates as measured by counting the number of patients who did not complete the treatment or who abandoned the treatment at some point;

 

Cured from TB as confirmed by Bacilloscopy, X-ray or culture and sensitivity tests that may or may not include an additional assessment of the patients for clinical signs and symptoms; and

 

All-cause mortality and mortality due to TB.

 

Types of studies

Randomized controlled trials and quasi-experimental studies will be considered for inclusion.

 

Search strategy

The search strategy aims to find both published and unpublished studies. A three-step search strategy will be utilized in this review. An initial limited search of MEDLINE and CINAHL will be undertaken, followed by analysis of the text words contained in the title and abstract and of the index terms used to describe the article. A second search using all identified keywords and index terms will then be undertaken across all included databases. Thirdly, the reference lists of all identified reports and articles will be searched for additional studies. Studies published in English, Portuguese and Spanish will be considered for inclusion in this review. The period of these studies will range from 1997, the date when the DOTS strategy was promoted internationally by the WHO,5 until the present (2014) when the search will be performed.

 

The databases to be searched include MEDLINE, CINAHL, LILACS, EMBASE and Cochrane Central Trials Register.

 

The keywords such as 'DOTS'; 'Directly Observed Treatment Short Course'; 'Supervised Treatment'; 'Standardized Treatment'; 'Observed Therapy of Tuberculosis'; 'Directly Observed Therapy'; 'Tuberculosis'; 'TB'; 'Educational Intervention'; 'Training' and 'Health Staff Training' will be used, alone or combined between themselves, in the search process.

 

The keywords, as well as the controlled descriptors, will be used alone or combined between themselves through the Boolean system. When necessary, they will be translated into Portuguese or Spanish to attend the specificities of any database, such as LILACS.

 

Assessment of methodological quality

Quantitative papers selected for retrieval will be assessed by two independent reviewers for methodological validity prior to inclusion in the review using the standardized critical appraisal instruments from the Joanna Briggs Institute Meta Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix I). Any disagreements that arise between the reviewers will be resolved through discussion, or with a third reviewer.

 

Data collection

Quantitative data will be extracted from papers included in the review using the standardized data extraction tool from JBI-MAStARI (Appendix II). The data extracted will include specific details about the interventions, populations, study methods and outcomes of significance to the review question and specific objectives.

 

The authors will extract data from individual studies independently.

 

Data synthesis

Quantitative papers will, where possible, be pooled in statistical meta-analysis using JBI-MAStARI. All results will be subject to double data entry. Effect sizes expressed as odds ratios (for categorical data) and weighted mean differences (for continuous data) and their 95% confidence intervals will be calculated for analysis. Heterogeneity will be assessed statistically using the standard chi-square and also explored using subgroup analyses based on the different quantitative study designs included in this review. Where statistical pooling is not possible, the findings will be presented in narrative form including tables and figures to aid in data presentation where appropriate.

 

Conflicts of interest

There is no conflict of interest.

 

Acknowledgements

None.

 

References

 

1. Walls T, Shingadia D. The Epidemiology of Tuberculosis in Europe. Arch Dis Child, 2007; 92:726-9. [Context Link]

 

2. World Health Organization. Global Tuberculosis control: surveillance, planning, financing: WHO Report 2005. Geneva: WHO; 2005. [Context Link]

 

3. World Health Organization. Global Tuberculosis Control: WHO Report 2011. Geneva: WHO; 2011.

 

4. World Health Organization (WHO). Global Tuberculosis Report. Geneva: WHO; 2012. [Context Link]

 

5. Pinet G. Good practice in legislation and regulations for TB control: an indicator of political will. Geneva: WHO; 2001. [Context Link]

 

6. World Health Organization (WHO)[Internet Homepage]. The Five elements of DOTS.; [Accessed in 2013 March 5]. Available from: http://www.who.int/tb/dots/whatisdots/en/index.html[Context Link]

 

7. World Health Organization (WHO). Treatment of Tuberculosis: guidelines-4th ed. Geneva: WHO; 2010. [Context Link]

 

8. Brasil-Ministerio da Saude. Manual de Recomendacoes para o controle da Tuberculose no Brasil. Brasilia/DF: Ministerio da Saude; 2011. [Context Link]

 

9. STOP TB PARTNERSHIP. The Global Plan to stop TB 2011-2015: transforming the fight towards elimination of Tuberculosis. Geneva: WHO, 2011-2015. [Context Link]

 

10. Frieden TR, Sbarbaro JA. Promoting adherence to treatment for tuberculosis: the importance of direct observation. Bull World Health Organ. 2007 May; 85(5):407-9. [Context Link]

 

11. Jasmer RM, Seaman CB, Gonzalez LC, Kawamura LM, Osmond DH, Daley CL. Tuberculosis Treatment Outcomes: Directly Observed Therapy Compared with Self-administered Therapy. Am J Respir Crit Care Med. 2004 Sep 1; 170 (5):561-6. [Context Link]

 

12. Gazzeta CE, Vendramini SHF, Ruffino-Neto A, Oliveira MR de C, Villa TCS. Estudo descritivo sobre a implantacao da estrategia de tratamento de curta duracao diretamente observado no controle da Tuberculose em Sao Jose do Rio Preto e seus impactos (1998-2003). J. Bras Pneumol. 2007; 33(2): 192-8. [Context Link]

 

13. World Health Organization (WHO)[Internet Homepage]. Tuberculosis: [Accessed in 2013 July 8]. Available from: http://www.who.int/mediacentre/factsheets/who104/en/print.html. [Context Link]

 

14. World Health Organization (WHO). WHO Report 2007: Global Tuberculosis Control, Surveillance, Planning, Financing. Geneva: WHO; 2007. [Context Link]

 

15. Figueroa-Munoz J, Palmer K, Poz MRD, Blanc L, Bergstrom K, Raviglione, M. The health workforce crisis in TB control: a report from high-burden countries. Hum. Resour. Health 2005; 3:2 [Context Link]

 

16. Albagli S, Maciel ML. Informacao e conhecimento na inovacao e no desenvolvimento local. Ci. Inf. 2004 set/dez; 33 (3): 9-16. [Context Link]

Appendix I: JBI- MAStARI appraisal instrument[Context Link]

Appendix II: JBI-MAStARI data extraction instrument[Context Link]

 

Keywords: Directly Observed Treatment Short-Course; Directly Observed Therapy; Educational Interventions; Health professional; Supervised Treatment; Tuberculosis